ESTRO-ESGO Quality indicators of radiation oncology treatment of cervical cancer patients

The ESGO together with the European Society of Radiotherapy and oncology (ESTRO) is developing the Cervical cancer radiation therapy quality indicators to improve overall quality of care for cervical cancer patients including the aspects of radiotherapy and brachytherapy.

The indicators aim at providing clinicians and health care authorities a quantitative background of optimal standard of care and evidence-based framework for improving quality of care across Europe at institutional and national level. The aim is also to improve oncologic outcomes by minimizing treatment related morbidity and complications profile and to homogenize treatment care across Europe and beyond.

The international development group consists of expert practising clinicians and researchers in the fields of radiotherapy, brachytherapy, and gynecological oncology.

The development group is chaired by Prof. Christina Fotopoulou (ESGO, United Kingdom) and Prof. Cyrus Chargari (ESTRO, France).

The article publication is expected in 2023.